These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12777952)

  • 1. Hormone replacement therapy causes a decrease in hepatocyte growth factor in hypertensive women.
    Tamama K; Sumino H; Ichikawa S; Kanda T; Kotajima N; Fukumura Y; Kurabayashi M; Murakami M
    J Hypertens; 2003 Jun; 21(6):1151-6. PubMed ID: 12777952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormone replacement therapy on office and ambulatory blood pressure in Japanese hypertensive postmenopausal women.
    Sumino H; Ichikawa S; Kumakura H; Takayama Y; Kanda T; Sakamaki T; Kurabayashi M
    Hypertens Res; 2003 May; 26(5):369-76. PubMed ID: 12887127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin.
    Sumino H; Ichikawa S; Kanda T; Sakamaki T; Nakamura T; Sato K; Kobayashi I; Nagai R
    Am J Hypertens; 1999 Oct; 12(10 Pt 1):1044-7. PubMed ID: 10560792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum level of vascular endothelial growth factor is decreased by hormone replacement therapy in postmenopausal women without hypercholesterolemia.
    Sumino H; Nakamura T; Ichikawa S; Kanda T; Sakamaki T; Sato K; Kobayashi I; Nagai R
    Atherosclerosis; 2000 Jan; 148(1):189-95. PubMed ID: 10580185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
    Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women.
    Miya Y; Sumino H; Ichikawa S; Nakamura T; Kanda T; Kumakura H; Takayama Y; Mizunuma H; Sakamaki T; Kurabayashi M
    Hypertens Res; 2002 Mar; 25(2):153-9. PubMed ID: 12047028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women.
    Nogawa N; Sumino H; Ichikawa S; Kumakura H; Takayama Y; Nakamura T; Kanda T; Mizunuma H; Kurabayashi M
    Menopause; 2001; 8(3):210-5. PubMed ID: 11355044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
    Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I
    Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype.
    Sumino H; Ichikawa S; Ohyama Y; Nakamura T; Kanda T; Sakamoto H; Sakamaki T; Mizunuma H; Kurabayashi M
    Hypertens Res; 2003 Jan; 26(1):53-8. PubMed ID: 12661913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients.
    Persico N; Mancini F; Artini PG; de Iaco P; Volpe A; de Aloysio D; Battaglia C
    Ultrasound Obstet Gynecol; 2005 Oct; 26(5):546-51. PubMed ID: 16184506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women.
    Sumino H; Ichikawa S; Sawada Y; Sakamoto H; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
    Thromb Res; 2005; 115(5):359-66. PubMed ID: 15733968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A; Sumino H; Ogawa T; Ichikawa S; Nitta K
    Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women.
    Hayward CS; Samaras K; Campbell L; Kelly RP
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):699-703. PubMed ID: 11465656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension.
    Nakamura S; Moriguchi A; Morishita R; Aoki M; Yo Y; Hayashi S; Nakano N; Katsuya T; Nakata S; Takami S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Biochem Biophys Res Commun; 1998 Jan; 242(1):238-43. PubMed ID: 9439642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure.
    Nakamura Y; Morishita R; Nakamura S; Aoki M; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1996 Sep; 28(3):409-13. PubMed ID: 8794825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
    Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
    Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients.
    Komai N; Ohishi M; Morishita R; Moriguchi A; Kaibe M; Matsumoto K; Rakugi H; Higaki J; Ogihara T
    Am J Hypertens; 2002 Jun; 15(6):499-506. PubMed ID: 12074350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study.
    Kaya C; Dinçer Cengiz S; Cengiz B; Akgün G
    Climacteric; 2006 Dec; 9(6):437-45. PubMed ID: 17085376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.